WO2011124050A1 - 瑞舒伐他汀钙中间体及制备方法 - Google Patents
瑞舒伐他汀钙中间体及制备方法 Download PDFInfo
- Publication number
- WO2011124050A1 WO2011124050A1 PCT/CN2010/075519 CN2010075519W WO2011124050A1 WO 2011124050 A1 WO2011124050 A1 WO 2011124050A1 CN 2010075519 W CN2010075519 W CN 2010075519W WO 2011124050 A1 WO2011124050 A1 WO 2011124050A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- reaction
- preparation
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- DMIIMPQQPXUKOO-UHFFFAOYSA-N CC(CC(C1)=O)CC1=O Chemical compound CC(CC(C1)=O)CC1=O DMIIMPQQPXUKOO-UHFFFAOYSA-N 0.000 description 1
- AEKZNMRSDWZFPF-CYBMUJFWSA-N CCOC(C[C@@H](CC(CBr)=O)OC(c1ccccc1)=O)=O Chemical compound CCOC(C[C@@H](CC(CBr)=O)OC(c1ccccc1)=O)=O AEKZNMRSDWZFPF-CYBMUJFWSA-N 0.000 description 1
- 0 COC(C[C@@](CC(C=*)=O)OC(c1ccccc1)=O)=O Chemical compound COC(C[C@@](CC(C=*)=O)OC(c1ccccc1)=O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
- C07F9/5352—Phosphoranes containing the structure P=C-
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/18—Preparation of carboxylic acid esters by conversion of a group containing nitrogen into an ester group
- C07C67/22—Preparation of carboxylic acid esters by conversion of a group containing nitrogen into an ester group from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/04—Calcium compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the invention relates to a novel pharmaceutical intermediate and a preparation method thereof, in particular to a novel preparation method of an important intermediate of rosuvastatin calcium.
- Rosuvastatin calcium chemical name (+)-(3W,5 -7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N -Methanesulfonylamino)pyrimidine-5-yl]- 3,5-dihydroxy-6CE)-heptenoic acid calcium (2:1) for primary hypercholesterolemia (Ill a, including heterozygotes) Patients with familial hypercholesterolemia or mixed lipodystrophy (li b) are adjuvanted when diet or exercise therapy is not ideal. It can lower elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increase HDL-cholesterol.
- the carboxy protecting group oxime must be a larger group to increase the stability of the ester group it protects and to increase the selectivity of hydrolysis of the monomethyl ester in the first step reaction. If the carboxy protecting group ⁇ is a smaller group such as a fluorenyl group, the difficulty of hydrolysis of the monomethyl ester is greatly increased, and the yield of the monomethyl ester hydrolyzate is low or even impossible. Therefore, the method The reserve cost is high and it is not suitable for industrialized mass production.
- the raw material anhydride compound used in the method is expensive, and the yield of the first-step reaction product is low, and there is also a problem of high production cost, which is not suitable for industrial mass production.
- a rosuvastatin calcium intermediate which is a compound represented by the formula I, which is suitable for industrial production.
- the method is simple and easy to control, has high yield, good purity and low relative cost.
- the method comprises the steps of: preparing a Wittig reaction from a compound of the formula V and triphenylphosphine under basic conditions; wherein R is an alkyl group, Y is a hydroxy protecting group, and X is a halogen atom.
- R is a C1 to C3 alkyl group
- Y is a tert-butyldimethylsilyl group, a benzyl group or a benzoyl group
- X is chlorine, bromine or iodine.
- the alkaline condition is that an alkali metal oxide, an alkaline earth metal oxide, a hydroxide, a carbonate, a hydrogencarbonate or a mixture thereof is added to the reaction liquid.
- an alkali metal oxide, an alkaline earth metal oxide, a hydroxide, a carbonate, a hydrogencarbonate or a mixture thereof is added to the reaction liquid.
- potassium carbonate, carbonic acid, potassium hydrogencarbonate, calcium hydrogencarbonate or a mixture thereof is added to the reaction liquid.
- the compound of the formula V is obtained by the following method:
- the compound of the formula IV is obtained by selectively oxidizing a hydroxyl group in a solvent A in the presence of a nitroxide radical, a selective oxidizing agent and a phase transfer catalyst.
- the solvent A is dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, butyl acetate, toluene, benzene, acetonitrile, acetone, butanone, n-hexane, cyclohexane, n-heptane, DMF, DMA, At least one or at least one mixture of DMSO and water.
- the nitroxide is a 2, 2, 6, 6-tetramethylpiperidine-N-oxygen compound.
- the selective oxidizing agent is sodium hypochlorite or sodium chlorite.
- the phase transfer catalyst is benzyltriethylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium hydrogen sulfate, trioctylmethylammonium chloride or cetyltrimethyl Methyl ammonium chloride.
- the compound of the formula IV is obtained by the following method: A compound represented by the formula III is produced by halogenation reaction with a reagent in a solvent B.
- the solvent B is dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, butyl acetate, toluene, benzene, acetonitrile, acetone, butanone, methanol, ethanol, isopropanol, n-hexane, cyclohexane, A mixture of at least one or at least one of n-heptane, DMF, DMA, DMSO and water.
- the temperature of the halogenation reaction is -10 to 50 °C.
- the preparation of the compound of formula III includes the following steps:
- the (2W)-1-cyano-2-hydroxy-4-pentene compound and an alcohol are subjected to alcoholysis reaction by acid catalysis to obtain a compound of the formula II; d.
- the compound of the formula II is protected with an alkali to give a compound of the formula III.
- the catalyst in the step a is cuprous chloride, cuprous iodide, cuprous cyanide, and the molar ratio of the catalyst to the epichlorohydrin pit is 0.10 0.15:1.
- the alkaline solvent in the step d is a mixture of imidazole and an organic solvent.
- the molar ratio of the imidazole to the compound of the formula II is from 1.5 to 2.5:1.
- X represents a halogen atom
- Y represents a hydroxy protecting group
- R represents an alkyl group.
- X is Br
- Y is a TBS protecting group
- R is a methyl group, that is, a compound represented by the formula ⁇ .
- X represents a halogen atom
- Y represents a hydroxy protecting group
- R represents an alkyl group.
- X is Br
- Y is a TBS protecting group
- R is a fluorenyl group, ie, a compound of formula VI:
- the beneficial effects of the present invention are as follows:
- the preparation of the rosuvastatin calcium intermediate of the present invention, that is, the compound of the formula I, is prepared by a synthesis method completely different from the prior art, and the method has simple conditions and no high temperature and high pressure reaction.
- the raw materials, catalysts and oxidants used are easy to purchase, and the process is stable, the product yield is high, no large amount of three wastes are produced, and environmental pollution is small, which is suitable for industrial large-scale production.
- reaction solution was further cooled to -35 ⁇ -25 °C, 30g of cuprous chloride was added, and 280g of epichlorohydrin was slowly added dropwise (the molar ratio of cuprous chloride to epichlorohydrin was 0.10-0.15: 1 Between;), keep the temperature at -35 ⁇ -25 °C during the dropwise addition, after 1-2 hours, transfer the reaction solution to 200ml of saturated ammonium chloride solution pre-cooled to 5 ⁇ 10 °C.
- the pH was adjusted to 3 to 4 with a hydrochloric acid solution having a concentration of 3 mol/L, and extracted with 150 ml of methyl tertiary ether in three portions, and the organic phases were combined, washed successively with 50 ml of a saturated sodium hydrogencarbonate solution and 50 ml of a saturated sodium chloride solution, and then at a temperature of The solvent was distilled off at 25 ⁇ 30 ° C under a vacuum of 250-350 Pa to obtain 306.9 g of a yellow-brown viscous liquid, ie (2W)-1-chloro-2-hydroxy-4-pentene, by high performance liquid chromatography. The purity of the method was 97.4%, and the yield was 81.9%.
- reaction solution was evaporated to a portion of methanol at a temperature of 35 ° C and a vacuum of 250 to 350 Pa, added to 400 ml of water and mixed uniformly, and extracted with 600 g of chloroform in three portions, and the organic phases were combined and washed with 200 ml of saturated sodium hydrogencarbonate solution, 100 g. After drying over anhydrous sodium sulfate, the solvent was evaporated under a temperature of 45 ° C to give 70.9 g of a brown liquid, Compound 11-1, HPLC: 91.0%, yield: 80.5%.
- the mixture of petroleum ether and ethyl acetate was monitored to complete the reaction of the compound II-1, the reaction solution was transferred to 100 ml of water, extracted three times with 150 g of dichloromethane, and the organic phases were combined, followed by 100 ml of saturated sodium bicarbonate solution and After washing with 100 ml of saturated sodium chloride solution, the solvent was distilled off at a temperature of 30-35 ° C and a vacuum of 250-350 Pa to obtain 63.1 g of a pale yellow liquid, that is, the compound ⁇ -1, which was purified by gas chromatography. It was 88.1% and the yield was 92.1%.
- the solvent was distilled off under the conditions of a temperature of 30 to 35 ° C and a vacuum of 250 to 350 Pa to obtain a pale yellow liquid, that is, a crude product of compound IV-1 (21.3 g), a gas chromatographic purity (GC) of 86.6%, a yield of 98.9%. .
- the reaction is quenched by the addition of saturated sodium thiosulfate, and the aqueous phase is separated by washing with water.
- the organic phase is washed with an appropriate amount of water and saturated brine, then dried over anhydrous sodium sulfate, filtered, and then at a temperature of 30-35
- the solution was concentrated under a vacuum of 250 to 350 Pa to obtain 20.5 g of a pale yellow liquid compound V1.
- the gas chromatographic purity (GC) was 70.0%, and the yield was 78.3%.
- Steps a and b are the same as a and b in the embodiment 1.
- reaction solution was evaporated to about 2/3 of isopropanol at a temperature of 35 ° C and a vacuum of 250 to 350 Pa, added to 400 ml of water and mixed uniformly, and extracted with 600 g of chloroform in three portions, and the organic phase was combined, and 200 ml was used. Wash with saturated sodium bicarbonate solution, dry with 100 g of anhydrous sodium carbonate, and then distill off the solvent at a temperature of 30-40 ° C and a vacuum of 250-350 Pa to obtain 84.7 g of brown liquid, ie, compound ⁇ -2, HPLC. The yield was 91.6% and the yield was 81.3%.
- reaction solution was transferred to 100 ml of water, extracted three times with 150 g of dichloromethane, and the organic phases were combined, washed successively with 100 ml of saturated sodium hydrogencarbonate solution and 100 ml of saturated sodium chloride solution, and then at a temperature of 30 to 35 ° C, vacuum degree.
- the solvent was distilled off under the conditions of 250 to 350 Pa to obtain 52.3 g of a pale yellow liquid, i.e., compound ⁇ -2, with a GC of 86.5% and a yield of 92.6%.
- the reaction is quenched by the addition of saturated sodium thiosulfate, and the aqueous phase is separated by washing with water.
- the organic phase is washed with an appropriate amount of water and saturated brine, and then dried over anhydrous sodium sulfate, filtered, and then the temperature is 30-35
- the concentration was 16.8 g of a pale yellow liquid compound IV-2 at a vacuum of 250 to 350 Pa, and the gas chromatographic purity (GC) was 72.2%, and the yield was 78.0 ⁇ 3 ⁇ 4.
- the oil was concentrated to a temperature of 30 to 35 ° C, and the degree of vacuum was 250 to 350 Pa to obtain an oily compound 1-2, and 40 g of ethyl acetate/petroleum ether (2:1) was added to crystallize, filtered, and dried to obtain 7.44 g of compound 1. -2, HPLC purity: 97.1%, ee value: 99.8%, yield 32.3%.
- Steps a and b are the same as a and b in the first embodiment, and step c is the same as c in the second embodiment.
- reaction solution is transferred to 100 ml of water, extracted three times with 150 g of dichloromethane, and the organic phase is combined, washed successively with 100 ml of saturated sodium hydrogencarbonate solution and 100 ml of saturated sodium chloride solution, and then at a temperature of 30-35.
- the solvent was distilled off under a vacuum of 250 to 350 Pa to obtain 56.7 g of a pale yellow liquid, i.e., the compound ⁇ -3, which was found to have a purity of 89.5% and a yield of 91.7% by gas phase color spectrometry.
- the oil was concentrated to a temperature of 30 to 35 ° C and a vacuum of 250 to 350 Pa to obtain an oily compound I -3 , which was crystallized by adding 60 g of ethyl acetate/petroleum ether (2:1), filtered, and dried to give 7.5 g of compound 1 -3, HPLC purity: 97.6%, ee value: 99.8%, yield 31.4%.
- Steps a and b are the same as a and b in the embodiment 1.
- the mixture was uniformly mixed with 400 ml of water, extracted three times with 600 g of chloroform, and the organic phases were combined and washed with 200 ml of saturated sodium hydrogencarbonate solution, 100 g. After drying over anhydrous sodium sulfate, the solvent was evaporated under a temperature of 45 ° C and a vacuum of 250 to 350 s to obtain 68.7 g of a brown liquid, i.e., compound 11 -3, HPLC: 93.5%, yield: 73.1 %.
- reaction solution was transferred to 100 ml of water, extracted three times with 150 g of dichloromethane, and the organic phases were combined, washed successively with 100 ml of saturated sodium hydrogencarbonate solution and 100 ml of saturated sodium chloride solution, and then at a temperature of 30 to 35 ° C, vacuum degree.
- the solvent was distilled off under the conditions of 250 to 350 Pa to obtain 55.3 g of a pale yellow liquid, i.e., compound oxime-3, which was determined by gas chromatography to have a purity of 89.9% and a yield of 91.6%.
- Steps a, b, c, and d are the same as a, b, c, and d in the embodiment 1.
- Steps a, b, c, and d are the same as a, b, c, and d in the embodiment 1.
- the organic phase is washed with an appropriate amount of water and saturated brine, and then dried over anhydrous sodium sulfate, filtered, and then the temperature is 30-35
- the concentration was 20.7 g of a pale yellow liquid compound V -6 at a vacuum of 250 to 350 Pa, and the gas chromatographic purity (GC) was 72.7%, and the yield was 75.6%.
- the compound 1-1 is concentrated, and 60 g of ethyl acetate/petroleum ether (2:1) is added to crystallize, filtered, and dried to obtain 5.0 g of compound 1. -1 , 1 ⁇ 1 ⁇ Purity: 97.4%, ee value: 96.8%, yield 23.7%.
- Steps a, b, c, and d are the same as a, b, c, and d in Example 1.
- Steps a and b are the same as a and b in the embodiment 1.
- the reaction solution was evaporated to a portion of ethanol at a temperature of 35 ° C and a vacuum of 250 to 350 Pa.
- the mixture was uniformly mixed with 285 ml of water, extracted three times with 430 g of chloroform, and the organic phases were combined and washed with 145 ml of saturated sodium hydrogen carbonate solution, 70 g
- the aqueous solution was dried over sodium sulfate, and the solvent was evaporated to dryness at 45 ° C to give 54.2 g of a brown liquid, Compound II -3, HPLC was 93.2%, yield: 79.5%.
- reaction solution was transferred to 100 ml of water, extracted three times with 150 g of dichloromethane, and the organic phase was combined, washed successively with 100 ml of saturated sodium hydrogen carbonate solution and 100 ml of saturated sodium chloride solution, and then at a temperature of 30-35 ° C, vacuum
- the solvent was distilled off under the conditions of 250 to 350 Pa to obtain 56.4 g of a pale yellow liquid, that is, the compound ⁇ -4, which was found to have a purity of 90.6% by gas chromatography, and the yield was 93.2%.
- the reaction is quenched by the addition of saturated sodium thiosulfate, and the aqueous phase is separated by washing with water.
- the organic phase is washed with an appropriate amount of water and saturated brine, and then dried over anhydrous sodium sulfate, filtered, and then the temperature is 30-35
- the mixture was concentrated under a vacuum of 250 to 350 Pa to obtain 19.0 g of a pale yellow liquid compound V - 4 .
- the gas chromatographic purity (GC ) was 72.6%, and the yield was 78.0%.
- Steps a, b, and c are the same as a, b, and c in the embodiment 1.
- reaction solution is transferred to 155 ml of water, extracted three times with 240 g of dichloromethane, and the organic phase is combined, washed successively with 155 ml of saturated sodium hydrogen carbonate solution and 155 ml of saturated sodium chloride solution, and then at a temperature of 30 to 35 ° C.
- the solvent was distilled off under the condition of a vacuum of 250 to 350 Pa to obtain 97.0 g of a pale yellow liquid, that is, compound 111-1.
- the purity was determined by a gas chromatography method to be 90.7%, and the yield was 92.2%.
- the solvent was distilled off under the conditions of a temperature of 30 to 35 ° C and a vacuum of 250 to 350 Pa to obtain a pale yellow liquid, that is, a crude compound IV-7 (30.2 g), a gas chromatographic purity (GC) of 89.3%, a yield of 96.4%. .
- the phase is separated, and the organic phase is washed with an appropriate amount of water and saturated brine, then dried over anhydrous sodium sulfate, filtered, and then the temperature is 30-35 ° (, vacuum concentration of 250 ⁇ 350Pa conditions to obtain 19.1g of light yellow liquid compound V-7, gas phase color purity (GC) 77.4%, yield 75.9%.
- GC gas phase color purity
- the oil is obtained by concentrating the compound 1-5 at a temperature of 30-35 ° C and a vacuum of 250-350 Pa, adding 50 g of ethyl acetate/petroleum ether (2:1), filtering, and drying to obtain 5.9 g of the compound. 1-5, HPLC purity: 98.3%, ee value: 98.8%, yield 29.5%.
- Steps a and b are the same as a and b in the embodiment 1, and step c is the same as c in the embodiment 4.
- reaction solution was transferred to 130 ml of water, extracted three times with 190 g of dichloromethane, and the organic phase was combined, followed by 130 ml of saturated sodium hydrogencarbonate solution and After washing with 130 ml of saturated sodium chloride solution, the solvent is distilled off at a temperature of 30-35 ° C and a vacuum of 250-350 Pa to obtain 75.5 g of a pale yellow liquid, that is, compound III-5, by gas chromatography. The purity was 89.6%, and the yield was 91.7%.
- reaction is quenched by the addition of saturated sodium thiosulfate, and the aqueous phase is separated by washing with water.
- the organic phase is washed with an appropriate amount of water and saturated brine, then dried over anhydrous sodium sulfate, filtered, and then at a temperature of 30-35 Concentrated under a condition of a vacuum of 250 to 350 Pa to obtain 17. lg of pale yellow liquid compound V-8, gas chromatography purity (GC) 71.8%, yield 79.5%.
- GC gas chromatography purity
- the compound 1-6 is obtained by concentrating at 30-35 ° C and a vacuum of 250-350 Pa, and adding 55 g of ethyl acetate/petroleum ether (2:1) to crystallize, filtering and drying to obtain 5.0 g of compound 1- 6, HPLC purity: 98.3%, ee value: 96.7%, yield 26.4%.
- Steps a, b are the same as a, b in Example 1
- steps c, d are the same as c, d in Example 4, and preparation of compound IV-9;
- the solvent was distilled off under the conditions of a temperature of 30 to 35 ° C and a vacuum of 250 to 350 Pa to obtain a pale yellow liquid, that is, a crude compound IV-9 (28.9 g), a gas chromatographic purity (GC) of 87.3%, a yield of 95.8%. .
- the reaction is quenched by the addition of saturated sodium thiosulfate, and the aqueous phase is separated by washing with water.
- the organic phase is washed with an appropriate amount of water and saturated brine, and then dried over anhydrous sodium sulfate, filtered, and then the temperature is 30-35
- the concentration was 19.6 g of a pale yellow liquid compound V -9 under a vacuum of 250 to 350 Pa, and the gas chromatographic purity (GC) was 73.9%, and the yield was 76.4%.
- the compound 1-4 is obtained by concentrating at 30-35 ° C and a vacuum of 250-350 Pa, and adding 50 g of ethyl acetate/petroleum ether (2:1) to crystallize, filtering and drying to obtain 4.5 g of compound 1- 4, HPLC purity: 97.4%, ee value: 95.8%, yield 23.2%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10849287.7A EP2557084B1 (en) | 2010-04-05 | 2010-07-28 | Rosuvastatin calcium intermediate and preparation method thereof |
| ES10849287.7T ES2485825T3 (es) | 2010-04-05 | 2010-07-28 | Intermedio de rosuvastatina cálcica y método de preparación del mismo |
| KR1020127022794A KR101486637B1 (ko) | 2010-04-05 | 2010-07-28 | 로슈바스타틴칼슘 중간생성물 및 그 제조방법 |
| SI201030675T SI2557084T1 (sl) | 2010-04-05 | 2010-07-28 | Kalcijev rosuvastatin polizdelek in postopek za njegovo pripravo |
| JP2012554193A JP5468145B2 (ja) | 2010-04-05 | 2010-07-28 | ロスバスタチンカルシウム中間生成物の調製方法 |
| IN7528CHN2012 IN2012CN07528A (cg-RX-API-DMAC7.html) | 2010-04-05 | 2010-07-28 | |
| US13/587,913 US8933269B2 (en) | 2010-04-05 | 2012-08-16 | Rosuvastatin calcium intermediate and method for preparing the same |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010162885 | 2010-04-05 | ||
| CN201010162885.7 | 2010-04-05 | ||
| CN201010179187.8A CN102212082B (zh) | 2010-04-05 | 2010-05-21 | 瑞舒伐他汀钙中间体及制备方法 |
| CN201010179187.8 | 2010-05-21 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/587,913 Continuation-In-Part US8933269B2 (en) | 2010-04-05 | 2012-08-16 | Rosuvastatin calcium intermediate and method for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011124050A1 true WO2011124050A1 (zh) | 2011-10-13 |
Family
ID=44743647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2010/075519 Ceased WO2011124050A1 (zh) | 2010-04-05 | 2010-07-28 | 瑞舒伐他汀钙中间体及制备方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8933269B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2557084B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5468145B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101486637B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102212082B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2485825T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2012CN07528A (cg-RX-API-DMAC7.html) |
| SI (1) | SI2557084T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011124050A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9315470B2 (en) | 2013-02-20 | 2016-04-19 | F.I.S.—Fabbrica Italiana Sintetiei S.p.A. | Convenient process for the preparation of statins |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102967683B (zh) * | 2012-11-16 | 2014-10-08 | 峨眉山天梁星制药有限公司 | 一种(3r)-叔丁基二甲硅氧基-5-氧代-6-三苯基膦烯己酸甲酯的高效液相色谱分析法 |
| CN104342410B (zh) * | 2013-07-26 | 2017-04-19 | 南京朗恩生物科技有限公司 | 一种酮还原酶突变体及其制备方法 |
| CN103421037B (zh) * | 2013-09-03 | 2015-12-23 | 浙江新东港药业股份有限公司 | 1-乙氧羰基-5-甲基-(3r)-叔丁基二甲硅氧基戊二酸酯的合成工艺 |
| CN103936680B (zh) * | 2014-04-18 | 2016-08-24 | 润泽制药(苏州)有限公司 | 瑞舒伐他汀钙已知杂质的制备方法 |
| CN104151345B (zh) * | 2014-08-05 | 2017-01-18 | 苏州维永生物医药技术有限公司 | 一种制备罗舒伐他汀钙中间体的方法 |
| CN105399770B (zh) * | 2015-11-23 | 2017-10-31 | 浙江科技学院 | 一种瑞舒伐他汀钙中间体的制备方法 |
| CN107382903B (zh) * | 2017-05-22 | 2021-02-26 | 重庆南松凯博生物制药有限公司 | 一种抗癌药物中间体的制备方法 |
| CN108845058A (zh) * | 2018-08-13 | 2018-11-20 | 江苏悦兴医药技术有限公司 | 一种瑞舒伐他汀钙起始物料的高效液相色谱检测方法 |
| CN111518073B (zh) * | 2019-02-01 | 2022-09-16 | 鲁南制药集团股份有限公司 | 一种瑞舒伐他汀侧链中间体的制备方法 |
| CN114075581A (zh) * | 2020-08-10 | 2022-02-22 | 广东东阳光药业有限公司 | 一种酯化合物的制备方法 |
| CN115677768A (zh) * | 2022-09-27 | 2023-02-03 | 宿迁阿尔法科技有限公司 | 一种(3r)-叔丁基二甲硅氧基-5-氧代-6-三苯基膦烯己酸甲酯的合成方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260440A (en) * | 1991-07-01 | 1993-11-09 | Shionogi Seiyaku Kabushiki Kaisha | Pyrimidine derivatives |
| US6689591B2 (en) * | 1999-07-09 | 2004-02-10 | Forschungszentrum Jülich GmbH | Method of reducing keto-carboxylic acids and their esters |
| WO2006091771A2 (en) | 2005-02-22 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| CN101624390A (zh) * | 2009-03-09 | 2010-01-13 | 鲁南制药集团股份有限公司 | 一种瑞舒伐他汀钙侧链关键中间体的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6471831A (en) * | 1987-09-11 | 1989-03-16 | Daiso Co Ltd | Optically active chlorohydrin derivative |
| JPH0710806B2 (ja) * | 1989-07-28 | 1995-02-08 | 株式会社クラレ | α―ケトカルボン酸エステルの製造方法 |
| JP2535436B2 (ja) * | 1990-07-16 | 1996-09-18 | 鐘淵化学工業株式会社 | 3,4―ジヒドロキシブチロニトリルの製造法 |
| JPH07247248A (ja) * | 1994-03-10 | 1995-09-26 | Kazuhiko Saigo | cis−2−アミノ−1−アセナフテノールのラセミ体および光学活性体、ならびにそれらの製造方法 |
| JP2003073332A (ja) * | 2001-06-20 | 2003-03-12 | Kuraray Co Ltd | 2−オキソカルボン酸エステル類の製造方法 |
| JP2003267907A (ja) * | 2002-03-14 | 2003-09-25 | Sumika Fine Chemicals Co Ltd | ケトンの製造方法 |
| JP2007291010A (ja) * | 2006-04-25 | 2007-11-08 | Daiso Co Ltd | 光学活性2−メチルエピハロヒドリン等の製造法 |
| JP2008266160A (ja) * | 2007-04-17 | 2008-11-06 | Sumitomo Chemical Co Ltd | ホスホラン化合物の製造方法 |
-
2010
- 2010-05-21 CN CN201010179187.8A patent/CN102212082B/zh active Active
- 2010-07-28 KR KR1020127022794A patent/KR101486637B1/ko active Active
- 2010-07-28 EP EP10849287.7A patent/EP2557084B1/en active Active
- 2010-07-28 WO PCT/CN2010/075519 patent/WO2011124050A1/zh not_active Ceased
- 2010-07-28 ES ES10849287.7T patent/ES2485825T3/es active Active
- 2010-07-28 JP JP2012554193A patent/JP5468145B2/ja active Active
- 2010-07-28 SI SI201030675T patent/SI2557084T1/sl unknown
- 2010-07-28 IN IN7528CHN2012 patent/IN2012CN07528A/en unknown
-
2012
- 2012-08-16 US US13/587,913 patent/US8933269B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260440A (en) * | 1991-07-01 | 1993-11-09 | Shionogi Seiyaku Kabushiki Kaisha | Pyrimidine derivatives |
| US6689591B2 (en) * | 1999-07-09 | 2004-02-10 | Forschungszentrum Jülich GmbH | Method of reducing keto-carboxylic acids and their esters |
| WO2006091771A2 (en) | 2005-02-22 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| CN101624390A (zh) * | 2009-03-09 | 2010-01-13 | 鲁南制药集团股份有限公司 | 一种瑞舒伐他汀钙侧链关键中间体的制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| GORDON E.M. ET AL.: "Synthesis of Substrate-based Inhibitors of HMG CoA Reductase.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS., vol. 1, no. 1, 1991, pages 61 - 64, XP055095607 * |
| J. ORG. CHEM., vol. 59, no. 25, 1994, pages 7849 - 7854 |
| See also references of EP2557084A4 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9315470B2 (en) | 2013-02-20 | 2016-04-19 | F.I.S.—Fabbrica Italiana Sintetiei S.p.A. | Convenient process for the preparation of statins |
| US9932361B2 (en) | 2013-02-20 | 2018-04-03 | F.I.S.—Fabbrica Italiana Sintetici S.p.A. | Convenient process for the preparation of statins |
Also Published As
| Publication number | Publication date |
|---|---|
| IN2012CN07528A (cg-RX-API-DMAC7.html) | 2015-06-19 |
| SI2557084T1 (sl) | 2014-10-30 |
| JP5468145B2 (ja) | 2014-04-09 |
| US8933269B2 (en) | 2015-01-13 |
| JP2013521225A (ja) | 2013-06-10 |
| CN102212082B (zh) | 2015-03-04 |
| EP2557084A1 (en) | 2013-02-13 |
| CN102212082A (zh) | 2011-10-12 |
| EP2557084A4 (en) | 2013-05-29 |
| ES2485825T3 (es) | 2014-08-14 |
| KR20120139722A (ko) | 2012-12-27 |
| US20120310000A1 (en) | 2012-12-06 |
| KR101486637B1 (ko) | 2015-01-26 |
| EP2557084B1 (en) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101486637B1 (ko) | 로슈바스타틴칼슘 중간생성물 및 그 제조방법 | |
| CN103980098B (zh) | 含二氟甲氧醚桥键(cf2o)的单体液晶化合物的制备方法 | |
| CN103539671B (zh) | 一种制备罗氟司特中间体的方法 | |
| JP2019081748A (ja) | ハロゲン化合物の製造方法 | |
| JP2005526049A (ja) | ベンゾイソキサゾールメタンスルホニルクロリドの調製及びゾニスアミドを形成するためのそのアミド化の方法 | |
| CN105175346A (zh) | 一种合成瑞舒伐他汀钙中间体的方法 | |
| CN113387799B (zh) | 一种γ,γ-二芳基酯或γ,γ,γ-三芳基酯化合物的制备方法及其产物 | |
| CN113387797B (zh) | 一种艾乐替尼关键中间体的制备方法 | |
| CN104513147B (zh) | 芴乙酮衍生物的制备方法 | |
| JP4356296B2 (ja) | 2−ナフトール誘導体の製造方法 | |
| JP2009508851A (ja) | β−ケトエステル化合物の製造方法 | |
| JP3496243B2 (ja) | 芳香族カルボン酸エステル類の製造方法 | |
| JPH05155846A (ja) | 4−メチルスルホニル安息香酸誘導体および中間体の改良された調製方法および中間体 | |
| WO2000024713A1 (fr) | Technique de preparation du retinol et de ses intermediaires | |
| CN108164431B (zh) | 2-羟基-5-(2,3,5,6-四氟-4-三氟甲基苄氨基)苯甲酸及其制备方法 | |
| JPH09188647A (ja) | アセトフェノン類の製造法 | |
| JP2000026359A (ja) | 芳香族−o−ジアルデヒド化合物の製造方法 | |
| CN1077188A (zh) | d1-萘普生的合成方法 | |
| JP4569002B2 (ja) | ブロモ芳香族縮環化合物の製造方法 | |
| JPS59225143A (ja) | ビフエニリルプロピオン酸誘導体およびその製造法 | |
| JPS6228156B2 (cg-RX-API-DMAC7.html) | ||
| JPH11322691A (ja) | 3,3−ジフルオロアラニン誘導体、その製造方法およびそれを用いた3,3−ジフルオロプロピオン酸誘導体の製造方法 | |
| JPH11222478A (ja) | スルホン誘導体の製造法 | |
| JP2001139554A (ja) | ハロゲン置換キノリン誘導体の製造方法 | |
| WO2006118187A1 (ja) | 2,2-ジクロロ-12-(4-ハロフェニル)ドデカン酸塩及びその製造中間体の製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10849287 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010849287 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012554193 Country of ref document: JP |
|
| ENP | Entry into the national phase |
Ref document number: 20127022794 Country of ref document: KR Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 7528/CHENP/2012 Country of ref document: IN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |